Outlook Therapeutics, Inc. — Form 8-K
Filed September 30, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 88/100
What the filing says
Outlook Therapeutics (market cap ~$26.9M) received a Notice of Delisting or Failure to Satisfy Continued Listing standards on September 25, 2026, filed via 8-K on September 30, 2026. The filing does not specify which exchange issued the notice, the specific rule(s) violated, cure timelines, or remedial actions. No financial impact, counterparties, or dollar amounts are detailed in the filing header.
Why this rating
Delisting threat is existential for micro-cap; loss of public listing destroys market access, liquidity, and valuation. Company scale makes this business-altering.
Extracted items
Price action (we called it negative)
before filing · preread $0.59 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.